CTT Pharmaceutical Holdings (CTTH) Financial Statements
CTT Pharmaceutical Holdings Financial Overview
CTT Pharmaceutical Holdings's market cap is currently $3.52M. The company's EPS TTM is $0.00; its P/E ratio is -45.38; CTT Pharmaceutical Holdings has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -6.43K | $ -6.40K | $ -6.40K | $ -6.40K | $ 0.00 |
| Operating Income | $ -126.77K | $ -250.00K | $ -42.09K | $ -109.00K | $ -148.00K |
| EBITDA | $ -120.34K | $ -243.83K | $ -35.70K | $ -44.71K | $ 103.56K |
| Net Income | $ -155.91K | $ -210.00K | $ -42.22K | $ -53.45K | $ -133.00K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 15.36K | $ 114.00 | $ 0.00 | $ 8.10K | $ 102.10K |
| Total Assets | $ 86.16K | $ 73.04K | $ 79.33K | $ 93.86K | $ 107.70K |
| Total Debt | $ 18.81K | $ 16.93K | $ 10.88K | $ 0.00 | $ 0.00 |
| Net Debt | $ 3.46K | $ 16.82K | $ 10.88K | $ -8.10K | $ -102.10K |
| Total Liabilities | $ 31.02K | $ 40.86K | $ 19.29K | $ 4.61K | $ 102.42K |
| Stockholders' Equity | $ 55.16K | $ 32.18K | $ 60.03K | $ 89.25K | $ 5.28K |
| Cash Flow | |||||
| Free Cash Flow | $ -75.47K | $ -33.87K | $ -21.10K | $ -138.84K | $ -600.25K |
| Operating Cash Flow | $ -75.47K | $ -228.32K | $ -21.10K | $ -138.84K | $ -600.25K |
| Investing Cash Flow | $ -4.31K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 95.03K | $ 228.43K | $ 13.00K | $ 44.84K | $ 500.37K |
Currency in USD
